首页|Several Considerations in Using Traditional Chinese Patent Medicine for Cerebral Infarction
Several Considerations in Using Traditional Chinese Patent Medicine for Cerebral Infarction
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Nowadays,a great number of traditional Chinese patent medicine (TCPM) are used more and more widely to treat cerebral infarction in China.When great attention is paid to using TCPM in the real world,several problems can be identified:ignoring the Chinese medicine (CM) therapeutic principle based on syndrome differentiation,a lack of appropriate dosage and usage based on individual patient conditions,and a shortage of evidence from randomized,double-blind,placebo-controlled clinical trials.Furthermore,in terms of evaluation of the TCPM effectiveness,few comprehensive criteria and evaluation methods recognized by the international community exist.This article addresses some opinions regarding the above mentioned problems.
cerebral infarctionischemic stroketraditional Chinese patent medicine
HE Jia、Yihyun Kwon、LI Chao、ZHANG Xue-qi、ZHAO Jian-guo
展开 >
Tianjin University of Traditional Chinese Medicine, Tianjin,300193, China
National University of Health Sciences
200 East Roosevelt, Rd., Lombard, IL 60148, USA
Department of Neurology of Integrated Traditional Chinese and Western Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin,300193, China
NETL
NSTL
万方数据
